Southeast Asia’s known for a lot of things. For one, we’re an awesome vacation destination. But it’s also being increasingly known for fertility care.

• At the same time, Asia has some of the world’s lowest birth rates. And infertility is a major concern.
• People usually work with third-party players and end up having to work with separate, siloed providers for their needs.

‍

Until Rhea! This Singapore-headquartered startup just raised an additional $10M.

• They’re a one-stop shop for reproductive care that connects families in Asia with their global network of solutions.
• They have over 380 staff across 12 markets.

Investor check. Thiel Capital led the round. LifeX Ventures, Blue Lion Global and FJ Labs also joined in!

• They initially raised $20M in 2023.
• They were incubated by Recharge Capital.

‍

💭 How it started

The original plan was to start a small roll-up of SEA-based clinics. But the company decided to do more than just build a network of clinics.

‍

👩🏻‍🍼 How it’s going

Today, they’ve officially launched Rhea. Their end-to-end service is an ecosystem of different services like:

GenPrime. A global network of their owned and partner clinics.

Rhea Labs. Here, they leverage tech and data to enhance patient outcomes and create leading products and tech.

• They are also developing RheaX, a global gamete exchange company that develops creative solutions to improve the process of matching and transferring gametes.
• They acquired Embryonics and integrated their AI-driven diagnostic tools into their product development pipeline and exclusive regional distribution rights with leading medical partners.

Fertility Wellness Partners. Partners like Moom Health, Elix Healing and Madam Partum offer other quality reproductive health products and services.

‍

💰 What’s with the $$$?

They’ll acquire more clinics, expand to more services in new markets, and grow their team.